Penbutolol: A New Beta Blocker in the Treatment of Moderate Essential Hypertension
- 1 July 1979
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 19 (7) , 384-389
- https://doi.org/10.1002/j.1552-4604.1979.tb02495.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Penbutolol in Hypertension: A Pilot Study with Single Daily DosesJournal of International Medical Research, 1977
- Beta‐2 adrenoceptor blocking activity of penbutolol and propranolol at very low dosesClinical Pharmacology & Therapeutics, 1977
- Long term treatment of moderate hypertension with penbutolol (hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemiaEuropean Journal of Clinical Pharmacology, 1976
- Long term treatment of moderate hypertension with penbutolol (Hoe 893d) III. Effects on glucose tolerance and insulin productionEuropean Journal of Clinical Pharmacology, 1976
- Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exerciseEuropean Journal of Clinical Pharmacology, 1975
- Adverse Reactions to ??-Adrenergic Receptor Blocking DrugsDrugs, 1974
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969